Xiyi Lu

Nanjing Medical University

*This is an algorithmically generated author record based on publicly available information.

See Latest Publications

See Most Cited Publications

ORCID Profile

Google Scholar

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Nanjing Medical University

Research Subjects

Research Interests

Xiyi Lu has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

Chen Zhang
Department of Oncology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China
21 shared publications
Dandan Yin
Clinical Research Center, The Second Hospital of Nanjing, Nanjing University of Chinese Medicine, Nanjing, China
21 shared publications
Erbao Zhang
Department of Epidemiology, Center for Global Health, School of Public Health, Nanjing Medical University, Nanjing, China
21 shared publications
Jiali Dai
Department of Oncology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China
21 shared publications
Jiali Xu
Department of Oncology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China
21 shared publications
Lei Song
Department of Oncology, First Affiliated Hospital of Nanjing Medical University, Nanjing, China
21 shared publications

Latest Publications

Sort by

Open Access
Website
Google Scholar
- 15 August 2025
- Published by American Association for Cancer Research (AACR)
Figure S2 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer
by Tianyu Qu, Lei Song, Jiali Xu, Xiyi Lu, Dandan Yin, Jiali Dai, Chen Zhang, Renhua Guo, Erbao Zhang
The effect of MYLK-AS1 expression on gefitinib resistance of NSCLC.
Website
Google Scholar
- 15 August 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S2 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer
by Tianyu Qu, Lei Song, Jiali Xu, Xiyi Lu, Dandan Yin, Jiali Dai, Chen Zhang, Renhua Guo, Erbao Zhang
The effect of MYLK-AS1 expression on gefitinib resistance of NSCLC.
Open Access
Website
Google Scholar
- 15 August 2025
- Published by American Association for Cancer Research (AACR)
Figure S10 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer
by Tianyu Qu, Lei Song, Jiali Xu, Xiyi Lu, Dandan Yin, Jiali Dai, Chen Zhang, Renhua Guo, Erbao Zhang
MYLK-AS1 promotes TKI resistance of lung cancer by regulating GLUD1.
Website
Google Scholar
- 15 August 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S10 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer
by Tianyu Qu, Lei Song, Jiali Xu, Xiyi Lu, Dandan Yin, Jiali Dai, Chen Zhang, Renhua Guo, Erbao Zhang
MYLK-AS1 promotes TKI resistance of lung cancer by regulating GLUD1.
Open Access
Website
Google Scholar
- 15 August 2025
- Published by American Association for Cancer Research (AACR)
Movie S1 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer
by Tianyu Qu, Lei Song, Jiali Xu, Xiyi Lu, Dandan Yin, Jiali Dai, Chen Zhang, Renhua Guo, Erbao Zhang
The quick rearrangement of ILF3 droplets. A time-lapse movie of droplets formed by ILF3 undergoes fusion event.
Website
Google Scholar
- 15 August 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Movie S1 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer
by Tianyu Qu, Lei Song, Jiali Xu, Xiyi Lu, Dandan Yin, Jiali Dai, Chen Zhang, Renhua Guo, Erbao Zhang
The quick rearrangement of ILF3 droplets. A time-lapse movie of droplets formed by ILF3 undergoes fusion event.
Open Access
Website
Google Scholar
- 15 August 2025
- Published by American Association for Cancer Research (AACR)
Table S5 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer
by Tianyu Qu, Lei Song, Jiali Xu, Xiyi Lu, Dandan Yin, Jiali Dai, Chen Zhang, Renhua Guo, Erbao Zhang
A list of top five potential MYLK-AS1-interacting protein candidates in PC9/GR cells based on RNA-protein pull-down assays and mass spectrometry analysis.
Website
Google Scholar
- 15 August 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Table S5 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer
by Tianyu Qu, Lei Song, Jiali Xu, Xiyi Lu, Dandan Yin, Jiali Dai, Chen Zhang, Renhua Guo, Erbao Zhang
A list of top five potential MYLK-AS1-interacting protein candidates in PC9/GR cells based on RNA-protein pull-down assays and mass spectrometry analysis.
Open Access
Website
Google Scholar
- 15 August 2025
- Published by American Association for Cancer Research (AACR)
Figure S5 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer
by Tianyu Qu, Lei Song, Jiali Xu, Xiyi Lu, Dandan Yin, Jiali Dai, Chen Zhang, Renhua Guo, Erbao Zhang
METTL3 induces the expression of MYLK-AS1 and promotes TKI resistance.
Website
Google Scholar
- 15 August 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S5 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer
by Tianyu Qu, Lei Song, Jiali Xu, Xiyi Lu, Dandan Yin, Jiali Dai, Chen Zhang, Renhua Guo, Erbao Zhang
METTL3 induces the expression of MYLK-AS1 and promotes TKI resistance.
Open Access
Website
Google Scholar
- 15 August 2025
- Published by American Association for Cancer Research (AACR)
Table S3 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer
by Tianyu Qu, Lei Song, Jiali Xu, Xiyi Lu, Dandan Yin, Jiali Dai, Chen Zhang, Renhua Guo, Erbao Zhang
Oligonucleotides sequences summary.
Website
Google Scholar
- 15 August 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Table S3 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer
by Tianyu Qu, Lei Song, Jiali Xu, Xiyi Lu, Dandan Yin, Jiali Dai, Chen Zhang, Renhua Guo, Erbao Zhang
Oligonucleotides sequences summary.
Open Access
Website
Google Scholar
- 15 August 2025
- Published by American Association for Cancer Research (AACR)
Figure S9 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer
by Tianyu Qu, Lei Song, Jiali Xu, Xiyi Lu, Dandan Yin, Jiali Dai, Chen Zhang, Renhua Guo, Erbao Zhang
MYLK-AS1 enhances the stability of GLUD1 mRNA by directly binding to ILF3.
Website
Google Scholar
- 15 August 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S9 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer
by Tianyu Qu, Lei Song, Jiali Xu, Xiyi Lu, Dandan Yin, Jiali Dai, Chen Zhang, Renhua Guo, Erbao Zhang
MYLK-AS1 enhances the stability of GLUD1 mRNA by directly binding to ILF3.
Open Access
Website
Google Scholar
- 15 August 2025
- Published by American Association for Cancer Research (AACR)
Figure S8 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer
by Tianyu Qu, Lei Song, Jiali Xu, Xiyi Lu, Dandan Yin, Jiali Dai, Chen Zhang, Renhua Guo, Erbao Zhang
MYLK-AS1 drives phase separation of ILF3 in PC9/OR.
Website
Google Scholar
- 15 August 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S8 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer
by Tianyu Qu, Lei Song, Jiali Xu, Xiyi Lu, Dandan Yin, Jiali Dai, Chen Zhang, Renhua Guo, Erbao Zhang
MYLK-AS1 drives phase separation of ILF3 in PC9/OR.
Open Access
Website
Google Scholar
- 15 August 2025
- Published by American Association for Cancer Research (AACR)
Figure S6 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer
by Tianyu Qu, Lei Song, Jiali Xu, Xiyi Lu, Dandan Yin, Jiali Dai, Chen Zhang, Renhua Guo, Erbao Zhang
METTL3-mediated post-transcriptional m6A modification contributes to the activation of MYLK-AS1 in TKI resistance of NSCLC.
Website
Google Scholar
- 15 August 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Figure S6 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer
by Tianyu Qu, Lei Song, Jiali Xu, Xiyi Lu, Dandan Yin, Jiali Dai, Chen Zhang, Renhua Guo, Erbao Zhang
METTL3-mediated post-transcriptional m6A modification contributes to the activation of MYLK-AS1 in TKI resistance of NSCLC.
Open Access
Website
Google Scholar
- 15 August 2025
- Published by American Association for Cancer Research (AACR)
Table S4 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer
by Tianyu Qu, Lei Song, Jiali Xu, Xiyi Lu, Dandan Yin, Jiali Dai, Chen Zhang, Renhua Guo, Erbao Zhang
MRNAs variation abundance (>=1.5-fold) in MYLK-AS1-knockdown PC9/GR cells.
Website
Google Scholar
- 15 August 2025
- Published by American Association for Cancer Research (AACR)
Open Access
Table S4 from MYLK-AS1 Enhances Glutamine Metabolism to Promote EGFR Inhibitor Resistance in Non–Small Cell Lung Cancer
by Tianyu Qu, Lei Song, Jiali Xu, Xiyi Lu, Dandan Yin, Jiali Dai, Chen Zhang, Renhua Guo, Erbao Zhang
MRNAs variation abundance (>=1.5-fold) in MYLK-AS1-knockdown PC9/GR cells.

Show all